Final Trades: Kimberly-Clark, Thermo Fisher, Wabtec and Berkshire Hathaway
The Investment Committee give you their top stocks to watch for the second half. Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.
Trade Tracker: Bill Baruch buys more Amgen
Bill Baruch, founder and president at Blue Line Capital, joins CNBC’s “Halftime Report” to detail his latest Amgen purchase. The Investment Committee debate the biotech sector. Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.
Is a greater rotation coming? Here’s what experts say
The Investment Committee debate whether a greater rotation is coming and if a December rate cut is on the table. Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.